30. Deputy Louise O'Reilly asked the Minister for Health his plans to undertake an investigation into the current and historical use of the drug, sodium valproate; if a State-wide register of those women who were on the medicine during pregnancy, and of the children affected by foetal anti-convulsant syndrome caused by exposure to sodium valproate during pregnancy, will be established; if appropriate pathways for the diagnosis and treatment of foetal anti-convulsant syndrome, in addition to providing additional services for children affected by this syndrome, will be put in place; and if he will make a statement on the matter. [48112/17]

Summary

30. Deputy Louise O'Reilly asked the Minister for Health his plans to undertake an investigation into the current and historical use of the drug, sodium valproate; if a State-wide register of those women who were on the medicine during pregnancy, and of the children affected by foetal anti-convulsant syndrome caused by exposure to sodium valproate during pregnancy, will be established; if appropriate pathways for the diagnosis and treatment of foetal anti-convulsant syndrome, in addition to providing additional services for children affected by this syndrome, will be put in place; and if he will make a statement on the matter. [48112/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Regulation

  xml · EN · 15 November 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.